Journal of Neurology

, Volume 252, Issue 11, pp 1379–1386

Cerebral Ischemic Infarction in Paroxysmal Nocturnal Hemoglobinuria

Report of 2 Cases and Updated Review of 7 Previously Published Patients
  • H. Audebert
  • J. Planck
  • M. Eisenburg
  • H. Schrezenmeier
  • R. L. Haberl
ORIGINAL COMMUNICATION

Abstract

Background

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal stem cell disorder, leading to a deficient biosynthesis of surface proteins in hematopoetic cells. Clinical symptoms consist of various combinations of intravascular hemolysis, bone marrow failure and mainly venous thrombotic events. Arterial thrombosis has been described only in a few cases.

Methods

We report two patients with fatal ischemic strokes in PNH caused by arterial occlusion. In addition we also reviewed 7 previously reported cases in the literature and obtained follow–up information on 4 of the 5 survivors.

Results

Both patients from our clinic had experienced hemoglobinuria and cytopenia prior to the vascular events but in one case diagnosis of PNH was only established after stroke onset. The causal role of PNH was supported by the absence of other vascular risk factors and by simultaneous symptoms of hemolysis and cytopenia. The diagnosis of PNH was confirmed by a positive result in flow cytometry. Despite extended therapeutic interventions, including antithrombotic treatment (with heparin or tirofiban) and decompressive hemicraniectomy both patients developed further thrombotic complications. The two patients died during their hospital stay from vascular or infectious complications. A review of all 9 published cases revealed that four patients died within a few weeks after the initial thrombotic event. No difference in treatment between patients with good or bad outcome was seen.

Conclusions

PNH is a rare cause of arterial stroke but it should be considered in young stroke patients with abnormal blood findings. As yet, there is no effective antithrombotic treatment.

Key words

paroxysmal nocturnal hemoglobinuria arterial stroke intravascular thrombosis cytopenia stem cell disorder 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    al Samman MB, Cuetter AC, Guerra LG, Ho H (1994) Cerebral arterial thrombosis as a complication of paroxysmal nocturnal hemoglobinuria. South Med J 87:765–767PubMedGoogle Scholar
  2. 2.
    Bemba M, Guardiola P, Garderet L, Devergie A, Ribaud P, Esperou H, Noguera MH, Gluckman E, Socie G (1999) Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria. Br J Haematol 105:366–368PubMedGoogle Scholar
  3. 3.
    Bessler M, Mason P, Hillmen P, Luzzatto L (1994) Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet 343:951–953CrossRefPubMedGoogle Scholar
  4. 4.
    Dacie JV (1963) Paroxysmal nocturnal haemoglobinuria. Proc R Soc Med 56:587–596PubMedGoogle Scholar
  5. 5.
    Graham DL, Gastineau DA (1992) Paroxysmal nocturnal hemoglobinuria as a marker for clonal myelopathy. Am J Med 93:671–674CrossRefPubMedGoogle Scholar
  6. 6.
    Grotta JC, Manner C, Pettigrew LC, Yatsu FM (1986) Red blood cell disorders and stroke. Stroke 17:811–817PubMedGoogle Scholar
  7. 7.
    Hall C, Richards S, Hillmen P (2003) Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood 102:3587–3591CrossRefPubMedGoogle Scholar
  8. 8.
    Hansen NE, Killmann SA (1970) Paroxysmal nocturnal hemoglobinuria in myelofibrosis. Blood 36:428–431PubMedGoogle Scholar
  9. 9.
    Heitzmann EJ, Campell JS, Stefanini M (1953) Paroxysmal nocturnal hemoglobinuria with hemosiderin nephrosis. Am J Clin Pathol 23:975–986Google Scholar
  10. 10.
    Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, Cullen MJ, Richards SJ, Rollins SA, Mojcik CF, et al. (2004) Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 350:552–559CrossRefPubMedGoogle Scholar
  11. 11.
    Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV (1995) Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 333:1253–1258CrossRefPubMedGoogle Scholar
  12. 12.
    Lin HC, Chen RL, Wang PJ (1996) Paroxysmal nocturnal hemoglobinuria presenting as moyamoya syndrome. Brain Dev 18:157–159CrossRefPubMedGoogle Scholar
  13. 13.
    McMullin MF, Hillmen P, Jackson J, Ganly P, Luzzatto L (1994) Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria. J Intern Med 235:85–89PubMedCrossRefGoogle Scholar
  14. 14.
    Murthy GL, Srinivasan VR, Gayatri K (2002) Cerebrovascular accident in paroxysmal nocturnal haemoglobinuria. J Assoc Physicians India 50:612PubMedGoogle Scholar
  15. 15.
    Nakahata J, Takahashi M, Fuse I, Nakamori Y, Nomoto N, Saitoh H, Tatewaki W, Imanari A, Takeshige T, Koike T, et al. (1993) Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia. Leuk Lymphoma 12:137–142PubMedCrossRefGoogle Scholar
  16. 16.
    Perkins HA, Boulware JM, Feichtmeir TV, Thayer WW, Spaet TH (1955) Paroxysmal nocturnal hemoglobinuria: report of four cases, with observations on treatment with 3:3’– methylenebis (4–hydroxycoumarin) (dicumarol). Ann Intern Med 43: 1218–1229PubMedGoogle Scholar
  17. 17.
    Rafalowska J, Dziewulska D, Szyluk B, Wieczorek J (1994) Morphological picture in paroxysmal nocturnal hemoglobinuria. Case report. Folia Neuropathol 32:161–166PubMedGoogle Scholar
  18. 18.
    Ranawaka UK, Alibhoy AT, Wijesekera JC (2001) Three young patients with unusual causes of stroke. Ceylon Med J 46:17–18PubMedGoogle Scholar
  19. 19.
    Reuther R, Storch B (1982) Carotid occlusion in paroxysmal nocturnal hemoglobinuria (Strubing–Marchiafava– Micheli). Nervenarzt 53:576–579PubMedGoogle Scholar
  20. 20.
    Rosse WF (1978) Paroxysmal nocturnal haemoglobinuria in aplastic anaemia. Clin Haematol 7:541–553PubMedGoogle Scholar
  21. 21.
    Rosse WF (1990) Phosphatidylinositollinked proteins and paroxysmal nocturnal hemoglobinuria. Blood 75:1595–1601PubMedGoogle Scholar
  22. 22.
    Saso R, Marsh J, Cevreska L, Szer J, Gale RP, Rowlings PA, Passweg JR, Nugent ML, Luzzatto L, Horowitz MM, et al. (1999) Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol 104:392–396CrossRefPubMedGoogle Scholar
  23. 23.
    Sholar PW, Bell WR (1985) Thrombolytic therapy for inferior vena cava thrombosis in paroxysmal nocturnal hemoglobinuria. Ann Intern Med 103:539–541PubMedGoogle Scholar
  24. 24.
    Socie G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, Heudier P, Rochant H, Cahn JY, Gluckman E (1996) Paroxysmal nocturnal haemoglobinuria: long–term follow–up and prognostic factors. French Society of Haematology. Lancet 348:573–577CrossRefPubMedGoogle Scholar
  25. 25.
    Stuckrad–Barre S, Berkefeld J, Steckel D, Sitzer M (2003) Cerebral arterial thrombosis in paroxysmal nocturnal hemoglobinuria. J Neurol 250:756–757Google Scholar
  26. 26.
    Wiedmer T, Hall SE, Ortel TL, Kane WH, Rosse WF, Sims PJ (1993) Complement– induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 82:1192–1196PubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2005

Authors and Affiliations

  • H. Audebert
    • 1
  • J. Planck
    • 1
  • M. Eisenburg
    • 2
  • H. Schrezenmeier
    • 3
  • R. L. Haberl
    • 1
  1. 1.Dept. of NeurologyStädtisches Krankenhaus, München–HarlachingMünchen HarlachingGermany
  2. 2.Dept. of TraumatologyMünchen HarlachingGermany
  3. 3.Institute of Transfusion Medicine and Immunogenetics and Dept. of Transfusion MedicineUniversity of UlmUlmGermany

Personalised recommendations